Apolipoprotein A IV (APOA4) and vitamin D binding protein (VDBP) significantly discriminated malignant from benign cases of ovarian cancer but was not as good as CA125 for diagnostic accuracy [45]. This evidence concerns the gene NBR1 and ovarian carcinoma.